Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

DosesSeries NameAbsolute Minimum IntervalMinimum IntervalRecommended IntervalLatest Recommended Interval (less than)
Dose 1 to 2Pfizer COVID-19 Series

8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age

Otherwise, 17 days

8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age

Otherwise, 21 days

8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age

Otherwise, 21 days

8 weeks

N/A

Dose 2 to 3


Pfizer COVID-19 Series8 weeks - 4 days8 weeks8 weeksN/A

...

Panel
borderColor#CCFFFF
bgColor#CCFFFF
titleBGColor#99FFFF
borderStylesolid

Series Special Rules

  • If the patient receives a shot at < 6 months old, evaluate the shot as Valid, with reason code SUPPLEMENTAL_TEXT; Descriptive Text: "The timing of the administration of this shot does not follow the guidelines regarding the minimum age."

    If a Pfizer bivalent vaccine (CVX 300, CVX 301, CVX 302) is inadvertently administered for the primary series, the shot is VALID.

  • If a Moderna bivalent vaccine (CVX 229, CVX 230) is inadvertently administered for the primary series, the shot is INVALID with reason code VACCINE_NOT_ALLOWED_FOR_THIS_DOSE. Ignore the bivalent vaccine (CVX 229, CVX 230) when determining the recommended due date for the next target dose due and when evaluating the next shot based on the absolute minimum interval for that target dose.
  • If CVX 302 is administered for target dose 3, there is no absolute maximum age for the vaccine.
  • If the patient receives a (valid) dose at >= 5 years of age and the shot was administered >= 4/19/2023, the series is complete.  

Vaccine to Recommend

  • Recommend at the vaccine group level.

Skip Dose Rule

  • Target Dose 3

    • If 2 or more doses were previously administered >= 5 years of age, target dose 3 is not needed. The series is complete.

    • If 2 doses of CVX 208, CVX 217, CVX 218, CVX 300 or CVX 301 were previously administered, target dose 3 is not needed. The series is complete.

Rule for CVX 212 (Janssen COVID-19 vaccine) 

  • If CVX 212 (Janssen COVID-19 vaccine) is reported for Target Dose 2, orTarget Dose 3, the Janssen COVID-19 Series applies and the series is complete. Therefore,  

    • evaluate the Target Dose (CVX 212) as Valid.

    • evaluate prior Target Doses as Accepted and the reason code is VACCINE_NOT_COUNTED_BASED_ON_MOST_RECENT_VACCINE_GIVEN.

...

Doses

Series Name

Absolute Minimum Interval

Minimum Interval

Minimum Recommended Interval

Latest Recommended Interval (less than)

Dose 1 to 2

Mixed Product COVID-19 Series

8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age

Otherwise:

  • 0 days if dose 2 administered < 10/25/2021
  • 24 days if dose 2 administered >= 10/25/2021

8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age

Otherwise, 28 days

8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age

Otherwise, 28 days

N/A
Dose 2 to 3Mixed Product COVID-19 Series8 weeks - 4 days8 weeks8 weeksN/A

...